GSK Invest ApS: Financial statements 2025
CVR: 40362541
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
GSK Invest ApS (CVR 40362541) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -14,099 and a net result of DKK 938,720 compared with DKK 1,055,884 the year before. Equity in the 2025 report amounted to DKK 6,526,830. The solvency ratio was 99.1%. The company had 1 employee in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK -14,099
- Profit/Loss
- DKK 938,720
- Equity
- DKK 6,526,830
- Total Assets
- DKK 6,586,105
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | -14K | 939K | 6.5M | 1 |
| 2024 | 0 | -29K | 1.1M | 5.7M | 1 |
| 2023 | 0 | -15K | 744K | 4.7M | - |
| 2022 | 0 | -12K | 1.1M | 4.2M | - |
| 2021 | 0 | -11K | 924K | 3.1M | - |
Official annual report
How creditworthy is GSK Invest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
GSK Invest ApS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK 1,055,884.
About GSK Invest ApS
GSK Invest ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2019. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Gorm Schmidt Knudsen. The company is owned by Gorm Schmidt Knudsen. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK -14,099 and a net result of DKK 938,720 compared with DKK 1,055,884 the year before. Equity in the 2025 report amounted to DKK 6,526,830.
